Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 6555 STATE HIGHWAY 161, IRVING, TX
- Founded
- Not disclosed
📈 Company Timeline
McKesson Corporation reported Regulation FD disclosure
McKesson Corporation filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
McKesson Corporation reported Regulation FD disclosure
McKesson Corporation filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
McKesson Corporation filed Form 10-Q
McKesson Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
McKesson Corporation reported Operating or financial results
McKesson Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
McKesson Corporation reported Shareholder voting results
McKesson Corporation filed an 8-K covering shareholder voting results.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q2 2026 | $105.38B | $1.32B | $614.00M | $5.15 | 10-Q · 5 Aug 2026 |
| Q4 2025 | $106.16B | $1.62B | $1.19B | $9.59 | 10-Q · 4 Feb 2026 |
| Q3 2025 | $103.15B | $1.41B | $1.11B | $8.92 | 10-Q · 6 Nov 2025 |
| Q2 2025 | $97.83B | $1.04B | $784.00M | $6.25 | 10-Q · 6 Aug 2025 |
| Q4 2024 | $95.29B | $1.22B | $879.00M | $6.95 | 10-Q · 6 Feb 2025 |
| Q3 2024 | $93.65B | $578.00M | $241.00M | $1.87 | 10-Q · 7 Nov 2024 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 845.00–1,200.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 12 hours ago